Page 71 - GPD-2-3

Gene & Protein in Disease Testosterone as a biomarker of colorectal cancer

Availability of data 11. Ahmad R, Singh JK, Wunnava A, et al., 2021, Emerging
trends in colorectal cancer: Dysregulated signaling pathways
All data analyzed were incorporated into the manuscript. (Review). Int J Mol Med, 47(3): 14.
References https://doi.org/10.3892/ijmm.2021.4847

1. Siegel RL, Miller KD, Wagle NS, et al., 2023, Cancer statistics, 12. Murphy N, Xu L, Zervoudakis A, et al., 2017, Reproductive
2023. CA Cancer J Clin, 73(1): 17–48. and menstrual factors and colorectal cancer incidence in the
women’s health initiative observational study. Br J Cancer,
https://doi.org/10.3322/caac.21763 116(1): 117–125.
2. Xi Y, Xu P, 2021, Global colorectal cancer burden in 2020 https://doi.org/10.1038/bjc.2016.345
and projections to 2040. Transl Oncol, 14(10): 101174.
13. Lin JH, Zhang SM, Rexrode KM, et al., 2013, Association
https://doi.org/10.1016/j.tranon.2021.101174 between sex hormones and colorectal cancer risk in
3. Mohd Y, Kumar P, Bhotla KH, et al., 2021, Transmission men and women. Clin Gastroenterol Hepatol, 11(4):
jeopardy of Adenomatosis polyposis coli and 419–424.e1.
methylenetetrahydrofolate reductase in colorectal cancer. https://doi.org/10.1016/j.cgh.2012.11.012
J Renin Angiotensin Aldosterone Syst, 2021: 7010706.
14. Shiels MS, Rohrmann S, Menke A, et al., 2009, Association
https://doi.org/10.1155/2021/7010706 of cigarette smoking, alcohol consumption, and physical
activity with sex steroid hormone levels in US men. Cancer
4. Bracci M, Zingaretti L, Martelli M, et al., 2023, Alterations in
pregnenolone and testosterone levels in male shift workers. Causes Control, 20: 877–886.
Int J Environ Res Public Health, 20(4): 3195–4011. https://doi.org/10.1007/s10552-009-9318-y
https://doi.org/10.3390/ijerph20043195 15. Sainz A, Rudolph R, Hein M, et al., 2011, Association
of genetic polymorphisms in ESR2, HSD17B1, ABCB1,
5. Roshan MH, Tambo A, Pace NP, 2016, The role of and SHBG genes with colorectal cancer risk. Endocr Relat
testosterone in colorectal carcinoma: Pathomechanisms and Cancer, 18(2): 265–276.
open questions. EPMA J, 7(1): 22.
https://doi.org/10.1530/ERC-10-0264
https://doi.org/10.1186/s13167-016-0071-5
16. Brenner H, Chen C, 2018, The colorectal cancer epidemic:
6. Murphy N, Strickler HD, Stanczyk FZ, et al., 2015, A Challenges and opportunities for primary, secondary and
prospective evaluation of endogenous sex hormone levels tertiary prevention. Br J Cancer, 119: 785–792.
and colorectal cancer risk in postmenopausal women. J Natl
Cancer Inst, 107: 210–227. https://doi.org/10.1038/s41416-018-0264-x
https://doi.org/10.1093/jnci/djv210 17. Younis M, Sujeetha P, Sangeetha T, et al., 2021, Molecular
heterogeneity in colorectal cancer: Insights from genetic
7. Vesper HW, Botelho JC, 2010, Standardization of profiling. J Adv Appl Sci Res, 3(5): 6–15.
testosterone measurements in humans. J Steroid Biochem
Mol Biol, 121(3–5): 513–519. https://doi.org/10.46947/joaasr352021118
https://doi.org/10.1016/j.jsbmb.2010.03.032 18. Dimou N, Mori N, Harlid S, et al., 2021, Circulating levels of
testosterone, sex hormone binding globulin and colorectal
8. Steinberger E, Ayala C, His B, et al., 1998, Utilization cancer risk: Observational and Mendelian randomization
of commercial laboratory results in management of analyses. Cancer Epidemiol Biomarkers Prev, 30(7):
hyperandrogenism in women. Endocr Pract, 4(1): 1–10. 1336–1348.
https://doi.org/10.4158/EP.4.1.1 https://doi.org/10.1158/1055-9965.EPI-20-1690
9. Rosner W, Auchus RJ, Azziz R, et al., 2007, Position 19. Mori N, Sawada N, Iwasaki M, et al., 2019, Circulating
statement: Utility, limitations, and pitfalls in measuring sex hormone levels and colorectal cancer risk in Japanese
testosterone: An endocrine society position statement. postmenopausal women: The JPHC nested case-control
J Clin Endocrinol Metab, 92(2): 405–413. study. Int J Cancer, 145: 1238–1244.
https://doi.org/10.1210/jc.2006-1864 https://doi.org/10.1002/ijc.32431
10. Bhasin S, Zhang A, Coviell A, et al., 2008, The impact of 20. Yeap BB, Almeida OP, Hyde Z, et al., 2007, In men older
assay quality and reference ranges on clinical decision than 70 years, total testosterone remains stable while free
making in the diagnosis of androgen disorders. Steroids, testosterone declines with age. The health in men study. Eur
73(13): 1311–1317. J Endocrinol, 156(5): 585–594.
https://doi.org/10.1016/j.steroids.2008.07.003 https://doi.org/10.1530/EJE-06-0714

Volume 2 Issue 3 (2023) 8 https://doi.org/10.36922/gpd.1082